当前位置: X-MOL 学术J. Neuroimmunol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
“Borderline” idiopathic CD4+ T-cell lymphocytopenia presenting with atypical progressive multifocal leukoencephalopathy
Journal of Neuroimmunology ( IF 3.3 ) Pub Date : 2020-12-01 , DOI: 10.1016/j.jneuroim.2020.577420
Clemente Dato , Andrea Elefante , Cinzia Coppola , Mariarosa Anna Beatrice Melone , Giacomo Lus , Antonella Costagliola , Giorgia Bruno , Gianfranco Puoti

Idiopathic CD4+ lymphocytopenia (ICL) is a rare disorder characterized by low counts of CD4+ cells (<300/mm3) in absence of other known causes of immunosuppression. A few cases of progressive multifocal leukoencephalopathy (PML) were reported in association with ICL with variable outcome. We describe the case of a 40 year-old man diagnosed with PML, which showed a monophasic course. Causes of primary and secondary immunodeficiency were ruled out, only a "borderline" ICL was found. This case highlights that a severe immunodepression could not be an absolute prerequisite in developing PML and also points the attention on current definition of ICL.

中文翻译:

“边缘性”特发性 CD4+ T 细胞淋巴细胞减少症表现为非典型进行性多灶性白质脑病

特发性 CD4+ 淋巴细胞减少症 (ICL) 是一种罕见的疾病,其特征是在没有其他已知的免疫抑制原因的情况下,CD4+ 细胞计数低 (<300/mm3)。据报道,一些进展性多灶性白质脑病 (PML) 病例与 ICL 相关,结果各不相同。我们描述了一个被诊断患有 PML 的 40 岁男性的病例,该病例呈单相病程。排除了原发性和继发性免疫缺陷的原因,只发现了“边缘”ICL。这个案例强调了严重的免疫抑制不能成为发展 PML 的绝对先决条件,也指出了对 ICL 当前定义的关注。
更新日期:2020-12-01
down
wechat
bug